Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment.
Wojciech ZarębaPiotr KrawiecMałgorzata BanaszkiewiczKrzysztof BatkoAleksandra GołąbDariusz PlicnerZbigniew Michał ŻuberBogdan BatkoPublished in: Reumatologia (2024)
Patients with RA initiating biologics should be screened for cardiometabolic risk factors, especially at an older age. The presence of at least one risk factor may be linked to a worse long-term prognosis.
Keyphrases
- risk factors
- cardiovascular risk factors
- rheumatoid arthritis patients
- disease activity
- rheumatoid arthritis
- cardiovascular disease
- metabolic syndrome
- systemic lupus erythematosus
- physical activity
- ankylosing spondylitis
- middle aged
- community dwelling
- combination therapy
- replacement therapy
- idiopathic pulmonary fibrosis